Opportunistic prostate cancer screening can lead to overdiagnosis of indolent diseases and invasive procedures. A cohort study suggested that a low baseline PSA level in midlife was associated with a ...

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Recent advances in prostate cancer awareness have transformed how the disease is detected and treated. New screening tools, including AI-enhanced MRI and urine-based biomarker tests, are catching ...

Every year, prostate cancer silently threatens hundreds of thousands of men, stealing lives and impacting families. It’s a stark reality: 1 in 8 men will face this diagnosis in their lifetime, and ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

The UK National Screening Committee (UK NSC) is poised to deliver its recommendations to the Government on Friday regarding expanded prostate cancer screening for men. Currently, the UK lacks a ...

Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...

Add Yahoo as a preferred source to see more of our stories on Google. Laura and Andrew, pictured on a holiday to Naxos, decided to book an appointment with Prof Mark Emberton to make further sense of ...

(CNN) — If you watched the Super Bowl, you probably saw commercials featuring NFL players telling America to “relax your tight end.” The campaign from drugmaker Novartis — called “Relax, It’s a Blood ...

In India, the second leading type of cancer found among males is prostate cancer, especially in cities like Delhi, Kolkata, Pune and Thiruvananthapuram. Data provided by the ICMR – National Institute ...